News & Media

News

November 20, 2023

Battelle, Andelyn Biosciences, and AmplifyBio Awarded Task Orders for Plasmid and Suspension AAV Vector Manufacturing and IND-enabling Studies from the National Institute of Neurological Disorders and Stroke (NINDS)

COLUMBUS, OH, Nov 20, 2023 – Battelle, Andelyn Biosciences, Inc., and AmplifyBio, have been awarded a new task order from the...

News

November 9, 2023

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

COLUMBUS, OH, Nov 9, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...

News

October 20, 2023

Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases

COLUMBUS, OH, OCTOBER 20, 2023 – Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and...

Connect Here With Our Business Team